Open Access
Table I.
SP600125 and SU6656 alleviated BEFV-mediated apoptosis.
Vero |
MDBK |
|||||
---|---|---|---|---|---|---|
Flow cytometry (% subG1) | Apoptotic ELISA (enrichment factor) | MTT (% viability) | Flow cytometry (% subG1) | Apoptotic ELISA (enrichment factor) | MTT (% viability) | |
Mock | 2.2 ± 0.15 | 1 | 100 | 2.8 ± 0.6 | 1 | 100 |
BEFV 2 moi | 67.5 ± 6.1 | 8.92 ± 1.42 | 28.6 ± 1.6 | 23.3 ± 2.4 | 9.05 ± 1.13 | 40.6 ± 3.5 |
BEFV+PD98059 | 60.2 ± 5.7 | 7.45 ± 2.12 | 25.4 ± 2.6 | 21.1 ± 2.1 | 7.21 ± 1.24 | 41.6 ± 2.9 |
BEFV+SB203580 | 63.3 ± 5.3 | 8.08 ± 1.63 | 31.2 ± 2.7 | 19.9 ± 1.7 | 7.68 ± 1.41 | 39.1 ± 3.1 |
BEFV+SP600125 | 23.5 ± 3.5 | 2.85 ± 0.91* | 76.2 ± 4.6* | 8.6 ± 1.9 | 2.35 ± 0.82* | 80.5 ± 3.7* |
BEFV+LY294002 | 59.9 ± 5.4 | 8.56 ± 1.93 | 32.2 ± 2.2 | 24.3 ± 2.3 | 7.07 ± 0.93 | 48.5 ± 2.1 |
BEFV+SU6656 | 19.6 ± 3.2 | 2.54 ± 0.82* | 83.1 ± 4.3* | 7.8 ± 1.7 | 2.36 ± 0.74* | 78.6 ± 5.7* |
BEFV+SP600125+SU6656 | 18.3 ± 2.8 | 2.86 ± 0.74* | 85.7 ± 3.9* | 7.1 ± 1.4 | 2.00 ± 0.81* | 82.7 ± 2.7* |